Full Text
Cost-Effectiveness of Dolutegravir, a New Generation Integrase Inhibitor, in Hiv-1 Treatment Experienced Patients in France

Abstract

Authors

N. Despiégel A.G. Marcellin C. Aubin C. Espinas A. Laurisse G. Pialoux

Back to Volume 17, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×